HI
HRTX icon

Harbour Investments’s Heron Therapeutics HRTX Stock Holding History

Harbour Investments’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28K Buy
12,365
+7,785
+170% +$6.24K ﹤0.01% 3670
2026
Q1 		$3.67K Buy
4,580
+3,580
+358% +$4.15K ﹤0.01% 3707
2025
Q4 		$1.3K Buy
+1,000
New +$1.24K ﹤0.01% 3403
2021
Q4 		– Sell
-1,188
Closed -$13K – 3099
2021
Q3 		$13K Sell
1,188
-170
-13% -$2.07K ﹤0.01% 2526
2021
Q2 		$21K Sell
1,358
-201
-13% -$3.2K ﹤0.01% 2321
2021
Q1 		$25K Buy
+1,559
New +$27.8K ﹤0.01% 2086

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Harbour Investments's HRTX Position: Q2 2026 in Review

Harbour Investments increased its Heron Therapeutics (HRTX) stake by 170% in Q2 2026, buying an estimated $6.24K and bringing the position to 12,365 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #3670.

Harbour Investments first reported a position in HRTX in Q1 2021 and has held it in 6 quarters since. The position peaked at $25K in Q1 2021. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Harbour Investments held 12,365 shares of Heron Therapeutics worth $5.28K as of Q2 2026.
  • Harbour Investments bought 7,785 Heron Therapeutics shares in Q2 2026, an estimated $6.24K.
  • Heron Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3670 holding.
  • Harbour Investments first reported a position in Heron Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • Harbour Investments's Heron Therapeutics position peaked at $25K in Q1 2021.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.